Cathy Eng MD FACP, FASCO

Gastrointestinal Cancer

Vanderbilt-Ingram Cancer Center; David H. Johnson Endowed Chair in Surgical and Medical Oncology; Professor of Medicine, Hematology and Oncology; VICC Associate Director for Strategic Relations and Research Partnerships; Executive Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee

Join to view full profile

3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000

Dr. Eng is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eng's full profile Already have an account?

Summary

Dr. Cathy Eng is an oncology specialist based in Nashville, TN, with subspecialties in gastrointestinal cancer and hematologic oncology. She completed her residency in internal medicine at Rush University Medical Center and her fellowship in hematology and medical oncology at the University of Chicago. Dr. Eng held a distinguished professorship at the University of Texas M.D. Anderson Cancer Center from 2002 to 2019. Her experience encompasses various cancers, including esophageal and colorectal cancer. Dr. Eng has numerous publications in the field and has contributed to several clinical trials focusing on advanced solid tumors and metastatic colorectal cancer. She has been honored with several awards, including recognition from the White House Cancer Moonshot and multiple top doctor accolades.

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1999 - 2002
Rush University Medical CenterResidency, Internal Medicine, 1996 - 1999
Rutgers Health/Cooperman Barnabas Medical CenterResidency, Radiology-Diagnostic, 1995 - 1996
Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 1994 - 1995
Drexel University College of MedicineClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2002 - 2028
TN State Medical License 2019 - 2027
IL State Medical License 1998 - 2026
AL State Medical License 2020 - 2020
NJ State Medical License 1995 - 1997
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Exceptional Women in Medicine Castle Connolly, 2019-2025
White House Cancer Moonshot Colorectal Cancer Panel: Colorectal Cancer Treatment, Innovation and support White House, 2023
Fellow Hedwig van Ameringen Executive Leadership in Academic Medicine, 2022

Clinical Trials

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
COMPLETED
PHASE2
S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer
WITHDRAWN
PHASE2
Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients
UNKNOWN

Publications & Presentations

PubMed

Early-Onset Gastric Cancer as a High-Risk Disease Entity in the United States: Clinicopathologic Features, Regional Variation, and Outcomes.
Dani R Castillo, Pranati Shah, Derek Tai, Mengni Guo, Max Hazeltine
Cancer Medicine. 2026-08-01
Amivantamab Monotherapy in Chemorefractory/Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.
Paul E Oberstein, J Randolph Hecht, Kanwal Raghav, Filippo Pietrantonio, Dirk Arnold
Journal of Clinical Oncology. 2026-06-10
Updates on Management of Anal Cancer: A New Era Has Begun.
Shalini Fernando, Van Morris, James Yu, Cathy Eng, Spencer Lessans
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2026-06-01

Journal Articles

Spectrum of Somatic Cancer Gene Variations Among Adults with Appendiceal Cancer by Age at Disease Onset
Cathy Eng, MD, JAMA Network Open

Lectures

The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients with Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled ...
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

ESMO 2025 Day 3 Highlights Not to MissOctober 19th, 2025
Spike in Early-Onset Cancers Takes Unique Toll on Oncologists, Patients: “A Real Phenomenon to Take Seriously”August 6th, 2025
Medical Centers Address Unique Needs of Young Adults with CancerApril 14th, 2025

Grant Support

Cultivating programmatic efforts to optimize the conduct and implementation of NCI-funded clinical trialsVANDERBILT UNIVERSITY MEDICAL CENTER2024–2029